Acute and Midterm Outcomes of Transcatheter Pulmonary Valve Replacement for Treatment of Dysfunctional Left Ventricular Outflow Tract Conduits in Patients With Aortopulmonary Transposition and a Systemic Right Ventricle
Author(s) -
Wendy Whiteside,
Justin T. Tretter,
Jamil Aboulhosn,
Osamah Aldoss,
Aimee K. Armstrong,
Martin L. Bocks,
Matthew J. Gillespie,
Thomas K. Jones,
Mary Hunt Martin,
Jeffrey Meadows,
Christina M. Metcalf,
Mariel E. Turner,
Thomas M. Zellers,
Bryan H. Goldstein
Publication year - 2017
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.116.004730
Subject(s) - medicine , cardiology , ventricular outflow tract , ventricle , great arteries , ejection fraction , heart failure
Transcatheter pulmonary valve replacement (TPVR) is an established therapy for dysfunctional right ventricular (RV) outflow tract conduits. TPVR in patients with congenitally corrected transposition of the great arteries, subpulmonary left ventricle, and left ventricular outflow tract (LVOT) conduit dysfunction has not been studied. Unique anatomic and physiological aspects of this population may contribute to distinct risks and outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom